Trial intelligence / Profile preview

Corticosteroid irrigation of major salivary glands for xerostomia after head and neck radiotherapy

jRCT1071210017Completed

Start
Oct 2022
Countries
1
01

Overview

Randomised, open-label trial in xerostomia (2 arms). Primary endpoint: Primary: xerostomia 4 weeks after treatment. Started Oct 2022; status: completed.

02

Conditions

xerostomia

Beyond the preview

Go deeper on jRCT1071210017.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1071210017.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call